| Keyan Mobli, MD | |
|
250 Blossom St Fl 4, Webster, TX 77598-4204 | |
| (832) 505-4000 | |
| (832) 632-7866 |
| Full Name | Keyan Mobli |
|---|---|
| Gender | Male |
| Speciality | Surgery - Trauma Surgery |
| Location | 250 Blossom St Fl 4, Webster, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134577877 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | BP10056566 (Texas) | Secondary |
| 2086S0127X | Surgery - Trauma Surgery | T7656 (Texas) | Primary |
| Entity Name | Utmb Faculty Group Practice |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942241146 PECOS PAC ID: 3375456734 Enrollment ID: O20031112000438 |
News Archive
The two ends of human DNA have different structures that are treated differently as a cell divides, UT Southwestern Medical Center researchers have found in a study that could help lead to cancer therapies.
Onyx Pharmaceuticals, Inc. today announced that the company has begun enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed multiple myeloma. The company has an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) and received Scientific Advice from the European Medicines Agency (EMA) on the design and planned analysis of the ASPIRE trial.
According to the 2012 Progress Report on U.S. Leadership in Global Agricultural Development (.pdf), released by the Chicago Council on Global Affairs on Thursday, "[t]he U.S. government risks losing the gains it has made in fighting world hunger unless it maintains its effort of the last three years in improving global agricultural practices and food security," Reuters reports.
MedShape Solutions, Inc. announced today the first FDA cleared shape memory PEEK (polyaryletheretherketone) device for orthopedics using proprietary shape memory PEEK Altera(TM) material. The Morphix(TM) Suture Anchor was recently granted FDA clearance and will be released to select U.S. markets in the coming months. Over $2.5B of PEEK-based implants are sold every year in the field of orthopedics.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Keyan Mobli, MD Po Box 650859, Dept. 710, Dallas, TX 75265-0859 Ph: (409) 772-0531 | Keyan Mobli, MD 250 Blossom St Fl 4, Webster, TX 77598-4204 Ph: (832) 505-4000 |
News Archive
The two ends of human DNA have different structures that are treated differently as a cell divides, UT Southwestern Medical Center researchers have found in a study that could help lead to cancer therapies.
Onyx Pharmaceuticals, Inc. today announced that the company has begun enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed multiple myeloma. The company has an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) and received Scientific Advice from the European Medicines Agency (EMA) on the design and planned analysis of the ASPIRE trial.
According to the 2012 Progress Report on U.S. Leadership in Global Agricultural Development (.pdf), released by the Chicago Council on Global Affairs on Thursday, "[t]he U.S. government risks losing the gains it has made in fighting world hunger unless it maintains its effort of the last three years in improving global agricultural practices and food security," Reuters reports.
MedShape Solutions, Inc. announced today the first FDA cleared shape memory PEEK (polyaryletheretherketone) device for orthopedics using proprietary shape memory PEEK Altera(TM) material. The Morphix(TM) Suture Anchor was recently granted FDA clearance and will be released to select U.S. markets in the coming months. Over $2.5B of PEEK-based implants are sold every year in the field of orthopedics.
› Verified 6 days ago
Mr. Yevgeny Shuhatovich, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 905 W Medical Center Blvd # 404, Webster, TX 77598 Phone: 281-985-9342 Fax: 281-393-0029 | |
Shitel Dineshbhai Patel, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 210 Genesis Blvd # B, Webster, TX 77598 Phone: 832-835-1131 Fax: 832-918-3223 | |
Lauren Nicole Hinojosa, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 525 Blossom St, Webster, TX 77598 Phone: 832-905-4186 Fax: 832-753-7457 | |
Hoang Pham, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 350 N Texas Ave, Suite A2, Webster, TX 77598 Phone: 281-616-6017 Fax: 281-947-3037 | |
In Soo Yo, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 450 W Medical Center Blvd, #600, Webster, TX 77598 Phone: 281-332-4596 Fax: 281-332-9610 | |
Tamer Dafashy, MD Surgery Medicare: Medicare Enrolled Practice Location: 150 E Medical Center Blvd Ste C, Webster, TX 77598 Phone: 281-316-4978 Fax: 281-316-2192 |